8Chen K,Shi Q,Kashiwada Y,et al.Anti-aids agents,6.salaspermic acid,an anti-HIV principle from Tripterygium wilfordii,and the structure-activity correlation with its related compounds.J Nat Prod,1992,55(3):340～346.
9Reddy VL,Reddy SM,Ravikanth V,et al.A new bis-andrographolide ether from Andrographis paniculata nees and evaluation of anti-HIV activity.Nat Prod Res,2005,19(3):223～230.
10Calabrese C,Berman SH,Babish JG,et al.A phase I trial of andrographolide in HIV positive patients and normal volunteers.Phytother Res,2000,14(5):333～338.
2[1]Wang YX,Neamati K,Jacob J,et al. Solution structure of anti-HIV-1 and anti-tumor proteins MAP30: structural insights into its multiple functions[J]. Cell,1999,99(4):433- 442.
3[2]Bourinbaiar AS,Lee-Huang S. The activitv of plant-derived antire troviral proteins MAP30 and GAP31 against herpes simplex virus infection in vitro[J]. Biochem Biophys Res Comm,1996,219(3):923-929.
4[3]Kapuscinski J,Skoczylas B. Simple and rapid fluorimetric method for DNA microassay [J]. Anal Biochem,1977,83(1):252-257.
5[4]Lee-Huang S,Huang PL,Nara PL,et al. MAP30: a new inhibition of HIV-1 infection and replication[J]. FEBS Lett,1990,272(1-2):12-18.
6[5]Lee-Huang S,Huang PL,Nara PL,et al. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant protion MAP30 and GAP31[J]. Proc Natl Acad Sci USA,1995,92(19):8818-8822.
7Lennerstrand J,Stammers D K,Larder B A.Biochemical mechanism of human immunodeficiency virus type 1 reverse transcriptase resistance to stavudine[J].Antimicrob Agents Chemother,2001,45(7):2144-2146.
8Hertogs K,Bloor S,De Vroey V,et al.A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V[J].Antimicrob Agents Chemother,2000,44(3):568-573.
9Girouard M,Diallo K,Marchand B,et al.Mutations E44D and V118I in the reverse transcriptase of HIV-1 play distinct mechanistic roles in dual resistance to AZT and 3TC[J].J Biol Chem,2003,278(36):34403-34410.
10Whitcomb J M,Parkin N T,Chappey C,et al.Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates[J].J Infect Dis,2003,188 (2003):992-1000.
